Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Study shows electric hand warmers improve comfort for breast cancer patients using scalp cooling during chemo
Study finds lower olanzapine dose equally effective for chemo-induced nausea with less drowsiness.
Immunotherapy improves pathological complete response and event-free survival in Asian TNBC patients.
Amcenestrant demonstrates antiproliferative effects and ER degradation in ER+/HER2- breast cancer patients.
Study finds vitamin D insufficiency may raise risk of chemotherapy-induced neuropathy in breast cancer.
Phase I/II trial shows adding oleclumab to standard therapy doesn't improve outcomes in advanced TNBC.
Novel drug combination significantly improves progression-free survival in HER2+ metastatic breast cancer
Study finds omega-3 supplements ineffective for preventing pain from paclitaxel chemotherapy in breast cancer
Study finds synbiotic supplements may reduce fatigue, GI issues in breast cancer patients on chemotherapy
9-week trastuzumab regimen nearly matches 1-year in long-term outcomes for early HER2+ breast cancer